They constantly renew and divide to help make exact replicas of on their own. Normal or usual cells multiply and divide, but they have limited lifespans.In January 2009, the US Meals and Drug Administration gave clearance to Geron Company for the 1st clinical trial of an embryonic stem-cell-primarily based therapy on humans. The trial aimed to eval